See also this year's filing and all EDGAR filings for this company.
PDF Report 0001505512_2016_Regulus_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001505512, Regulus Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 134,258,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,081,000 |
| 2 | PropertyPlantAndEquipmentNet | 5,400,000 |
| 3 | remainder_Assets | 344,000 |
| 4 | LiabilitiesCurrent | 12,632,000 |
| 5 | LiabilitiesNoncurrent | 2,308,000 |
| 6 | remainder_Liabilities | 2,065,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 57,114,986 |
| 9 | ResearchAndDevelopmentExpense | 91,540,641 |
| 10 | remainder_Expenses | 39,997 |
| 11 | remainder_Revenues | 17,454,798 |
| 12 | remainder_NetIncome | -12,094,181 |
| 13 | remainder_ComprehensiveNetIncome | -180,413 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 141,083,000 |
| 1 | Liabilities | 17,005,000 |
| 2 | Expenses | 148,695,624 |
| 3 | Revenues | 17,454,798 |
| 4 | StockholdersEquity | 124,078,000 |
| 5 | NetIncome | -143,335,007 |
| 6 | ComprehensiveNetIncome | -143,425,214 |
| 7 | BaseVar | 168,256,508 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.61 |
| 9 | EconomicCapitalRatio | 2.75 |
Edgar->Model Mapping
Feature Distribution
Change over Time
